Země: Arménie
Jazyk: angličtina
Zdroj: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
diclofenac (diclofenac diethylamine)
Novartis Consumer Health S.A.
diclofenac (diclofenac diethylamine)
10mg/g
gel for external use
OTC
Novartis Consumer Health Global Regulatory Affairs Global Labeling VOLTAREN EMULGEL Gel Diclofenac diethylamine 1.16% SMPC The National Product Information (and Regional Product Information) is based on the SmPC. However, because national regulatory requirements and medical practices vary between countries, the National (and Regional) Product Information may differ in several respects, including but not limited to the Core Safety Information. Author(s): Babu Selvam Document status: FINAL GLC approval date: 02 Dec 2010, 29 Sep 2011 GLC tracking ID: 2010 Dec 02/06-N, 2011-Sep-29/04-N Amendment date(s): 3 Dec 2009, 17 Jun 2010, 18 Nov 2010, 02 Dec 2010, 29 Sep 2011 Effective date: 05 Oct 2011 Next update date: Sep 2014 Number of pages: 7 Property of Novartis Consumer Health Novartis CONFIDENTIAL Page 2 Voltaren DEA 1.16% range TABLE OF CONTENTS 1 NAME OF THE MEDICINAL PRODUCT .......................................................................3 2 QUALITATIVE AND QUANTITATIVE COMPOSITION .............................................3 3 PHARMACEUTICAL FORM............................................................................................3 4 CLINICAL PARTICULARS ..............................................................................................3 4.1 Therapeutic indications............................................................................................3 4.2 Posology and method of administration ..................................................................3 4.3 Contraindications ..................................................................................................... 4 4.4 Special warnings and precautions for use................................................................4 4.5 Interaction with other medicinal products and other forms of interaction ..............4 4.6 Pregnancy and lactation...........................................................................................4 4.7 Effects on ability to drive and use machines .................................... Přečtěte si celý dokument